Skip to content

Total Assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
Xencor logo
XencorXNCR
$736.85M-18.6%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Vor Biopharma logo
Vor BiopharmaVOR
$506.75M+364%

Other financials

Income statement

See full
Revenue$3.7M
Operating income-$34.2M+2.0%
Net income-$24.4M-3.6%
EPS (diluted)-$0.39-2.6%

Balance sheet

See full
Cash & equivalents$51.8M-29.7%
Total debt$21.6M-4.6%
Total equity$941.5M-7.0%

Cash flow

See full
Operating cash flow-$12.3M+27.5%
CapEx$273.0K-26.4%
Free cash flow-$12.6M+27.5%

Valuation

See full
Market cap$892.81M-36.1%
Enterprise value$862.55M-35.9%
P/S65×-84.6×

Profitability

See full
Operating margin-1,143.1%-65.1pp
Net margin-833.6%+0.9pp
FCF margin-571.6%+98.3pp

Returns & leverage

See full
Return on equity-11.7%+4.1pp
Debt / equity0.0×
Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Janux Therapeutics's total assets?
Janux Therapeutics (JANX) reported total assets of $1.03B in Q1 2026.
How has Janux Therapeutics's total assets changed year-over-year?
Janux Therapeutics's total assets decreased by 2.1% year-over-year, from $1.05B to $1.03B.
What is the long-term trend for Janux Therapeutics's total assets?
Over 5 years (2020 to 2025), Janux Therapeutics's total assets has grown at a 128.1% compound annual growth rate (CAGR), from $16.22M to $1B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.